Loading…

Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis

To investigate whether carbon nanoparticles (CNs) are helpful in identifying lymph nodes and metastatic lymph nodes and in parathyroid protection during thyroid cancer surgery. English and Chinese literature in PubMed, Cochrane Database of Systematic Reviews, EMBASE, ClinicalTrials.gov, China Biolog...

Full description

Saved in:
Bibliographic Details
Published in:OncoTargets and therapy 2017-01, Vol.10, p.1247-1260
Main Authors: Wang, Lun, Yang, Dong, Lv, Jun-Yuan, Yu, Dan, Xin, Shi-Jie
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c573t-88a07f5821d9a2c8b184da1606c9720ed3d2ef9ba336802f807658f2e571201b3
cites
container_end_page 1260
container_issue
container_start_page 1247
container_title OncoTargets and therapy
container_volume 10
creator Wang, Lun
Yang, Dong
Lv, Jun-Yuan
Yu, Dan
Xin, Shi-Jie
description To investigate whether carbon nanoparticles (CNs) are helpful in identifying lymph nodes and metastatic lymph nodes and in parathyroid protection during thyroid cancer surgery. English and Chinese literature in PubMed, Cochrane Database of Systematic Reviews, EMBASE, ClinicalTrials.gov, China Biology Medicine Database, China National Knowledge Infrastructure, China Master's and Doctoral Theses Full-Text Database, Wanfang database, and Cqvip database were searched (till March 22, 2016). Randomized controlled trials (RCTs) that compared the use of CNs with a blank control in patients undergoing thyroid cancer surgery were included. Quality assessment and data extraction were performed, and a meta-analysis was conducted using RevMan 5.1 software. The primary outcomes were the number of retrieved central lymph nodes and metastatic lymph nodes, and the rate of accidental parathyroid removal. We obtained 149 relevant studies, and only 47 RCTs with 4,605 patients (CN group: n=2,197; blank control group: n=2,408) met the inclusion criteria. Compared with the control group, the CN group was associated with more retrieved lymph nodes/patient (weighted mean difference [WMD]: 3.39, 95% confidence interval [CI]: 2.73-4.05), more retrieved metastatic lymph nodes (WMD: 0.98, 95% CI: 0.61-1.35), lower rate of accidental parathyroid removal, and lower rates of hypoparathyroidism and hypocalcemia. However, the total metastatic rate of the retrieved lymph nodes did not differ between the groups (odds ratio: 1.13, 95% CI: 0.87-1.47, =0.35). CNs can improve the extent of neck dissection and protect the parathyroid glands during thyroid cancer surgery. And the number of identified metastatic lymph nodes can be simultaneously increased.
doi_str_mv 10.2147/ott.s131012
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5338936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534206574</galeid><sourcerecordid>A534206574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-88a07f5821d9a2c8b184da1606c9720ed3d2ef9ba336802f807658f2e571201b3</originalsourceid><addsrcrecordid>eNptkk2LFDEQhhtR3HX15F0CgggyYz466bQHYVj8goU9OJ5DJl09kyWdtEl6Zf6Mv9XMzuw6I5JDinqfeotUqqpeEjynpG7eh5zniTCCCX1UnRPSyJloGX58FJ9Vz1K6wVgISeun1RmVVGLG2_Pq92IcnTU62-BR6JHRcVUir30YdczWOEjIeuS2w7hBPnSAOpsSmLsC7TtUMJ032xhsiWPIB6mbovVrdK8Y7Q1ElKa4hmghfUAapW3KMJTWBkW4tfDrzm-ArGfaa7dNNj2vnvTaJXhxuC-qH58_LS-_zq6uv3y7XFzNDG9YnkmpcdNzSUnXamrkisi600RgYdqGYuhYR6FvV5oxITHtJW4Elz0F3hCKyYpdVB_3vuO0GqAz4HPUTo3RDjpuVdBWnSrebtQ63CrOmGyZKAZvDwYx_JwgZTXYZMA57SFMSRHZiLqt64YV9PU_6E2YYnlwUpTWtBact_wvtdYOlPV9KH3NzlQtOKspFrypCzX_D1VOB4M1wUNvS_6k4M1RwQa0y5sU3LT7s3QKvtuDJoaUIvQPwyBY7fZOXS-X6vt-7wr96nh-D-z9orE_vdPVXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242465595</pqid></control><display><type>article</type><title>Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis</title><source>Open Access: PubMed Central</source><source>Taylor &amp; Francis Open Access</source><source>ProQuest - Publicly Available Content Database</source><creator>Wang, Lun ; Yang, Dong ; Lv, Jun-Yuan ; Yu, Dan ; Xin, Shi-Jie</creator><creatorcontrib>Wang, Lun ; Yang, Dong ; Lv, Jun-Yuan ; Yu, Dan ; Xin, Shi-Jie</creatorcontrib><description>To investigate whether carbon nanoparticles (CNs) are helpful in identifying lymph nodes and metastatic lymph nodes and in parathyroid protection during thyroid cancer surgery. English and Chinese literature in PubMed, Cochrane Database of Systematic Reviews, EMBASE, ClinicalTrials.gov, China Biology Medicine Database, China National Knowledge Infrastructure, China Master's and Doctoral Theses Full-Text Database, Wanfang database, and Cqvip database were searched (till March 22, 2016). Randomized controlled trials (RCTs) that compared the use of CNs with a blank control in patients undergoing thyroid cancer surgery were included. Quality assessment and data extraction were performed, and a meta-analysis was conducted using RevMan 5.1 software. The primary outcomes were the number of retrieved central lymph nodes and metastatic lymph nodes, and the rate of accidental parathyroid removal. We obtained 149 relevant studies, and only 47 RCTs with 4,605 patients (CN group: n=2,197; blank control group: n=2,408) met the inclusion criteria. Compared with the control group, the CN group was associated with more retrieved lymph nodes/patient (weighted mean difference [WMD]: 3.39, 95% confidence interval [CI]: 2.73-4.05), more retrieved metastatic lymph nodes (WMD: 0.98, 95% CI: 0.61-1.35), lower rate of accidental parathyroid removal, and lower rates of hypoparathyroidism and hypocalcemia. However, the total metastatic rate of the retrieved lymph nodes did not differ between the groups (odds ratio: 1.13, 95% CI: 0.87-1.47, =0.35). CNs can improve the extent of neck dissection and protect the parathyroid glands during thyroid cancer surgery. And the number of identified metastatic lymph nodes can be simultaneously increased.</description><identifier>ISSN: 1178-6930</identifier><identifier>EISSN: 1178-6930</identifier><identifier>DOI: 10.2147/ott.s131012</identifier><identifier>PMID: 28280359</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Biopsy ; Cancer surgery ; Carbon ; Care and treatment ; Dissection ; Endoscopy ; Lymph node excision ; Lymphatic system ; Meta-analysis ; Metastasis ; Nanomaterials ; Nanoparticles ; Nanotubes ; Original Research ; Parathyroid diseases ; Patients ; Risk factors ; Systematic review ; Thyroid cancer</subject><ispartof>OncoTargets and therapy, 2017-01, Vol.10, p.1247-1260</ispartof><rights>COPYRIGHT 2017 Dove Medical Press Limited</rights><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Wang et al. This work is published and licensed by Dove Medical Press Limited 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-88a07f5821d9a2c8b184da1606c9720ed3d2ef9ba336802f807658f2e571201b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2242465595/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2242465595?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28280359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Lun</creatorcontrib><creatorcontrib>Yang, Dong</creatorcontrib><creatorcontrib>Lv, Jun-Yuan</creatorcontrib><creatorcontrib>Yu, Dan</creatorcontrib><creatorcontrib>Xin, Shi-Jie</creatorcontrib><title>Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis</title><title>OncoTargets and therapy</title><addtitle>Onco Targets Ther</addtitle><description>To investigate whether carbon nanoparticles (CNs) are helpful in identifying lymph nodes and metastatic lymph nodes and in parathyroid protection during thyroid cancer surgery. English and Chinese literature in PubMed, Cochrane Database of Systematic Reviews, EMBASE, ClinicalTrials.gov, China Biology Medicine Database, China National Knowledge Infrastructure, China Master's and Doctoral Theses Full-Text Database, Wanfang database, and Cqvip database were searched (till March 22, 2016). Randomized controlled trials (RCTs) that compared the use of CNs with a blank control in patients undergoing thyroid cancer surgery were included. Quality assessment and data extraction were performed, and a meta-analysis was conducted using RevMan 5.1 software. The primary outcomes were the number of retrieved central lymph nodes and metastatic lymph nodes, and the rate of accidental parathyroid removal. We obtained 149 relevant studies, and only 47 RCTs with 4,605 patients (CN group: n=2,197; blank control group: n=2,408) met the inclusion criteria. Compared with the control group, the CN group was associated with more retrieved lymph nodes/patient (weighted mean difference [WMD]: 3.39, 95% confidence interval [CI]: 2.73-4.05), more retrieved metastatic lymph nodes (WMD: 0.98, 95% CI: 0.61-1.35), lower rate of accidental parathyroid removal, and lower rates of hypoparathyroidism and hypocalcemia. However, the total metastatic rate of the retrieved lymph nodes did not differ between the groups (odds ratio: 1.13, 95% CI: 0.87-1.47, =0.35). CNs can improve the extent of neck dissection and protect the parathyroid glands during thyroid cancer surgery. And the number of identified metastatic lymph nodes can be simultaneously increased.</description><subject>Biopsy</subject><subject>Cancer surgery</subject><subject>Carbon</subject><subject>Care and treatment</subject><subject>Dissection</subject><subject>Endoscopy</subject><subject>Lymph node excision</subject><subject>Lymphatic system</subject><subject>Meta-analysis</subject><subject>Metastasis</subject><subject>Nanomaterials</subject><subject>Nanoparticles</subject><subject>Nanotubes</subject><subject>Original Research</subject><subject>Parathyroid diseases</subject><subject>Patients</subject><subject>Risk factors</subject><subject>Systematic review</subject><subject>Thyroid cancer</subject><issn>1178-6930</issn><issn>1178-6930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk2LFDEQhhtR3HX15F0CgggyYz466bQHYVj8goU9OJ5DJl09kyWdtEl6Zf6Mv9XMzuw6I5JDinqfeotUqqpeEjynpG7eh5zniTCCCX1UnRPSyJloGX58FJ9Vz1K6wVgISeun1RmVVGLG2_Pq92IcnTU62-BR6JHRcVUir30YdczWOEjIeuS2w7hBPnSAOpsSmLsC7TtUMJ032xhsiWPIB6mbovVrdK8Y7Q1ElKa4hmghfUAapW3KMJTWBkW4tfDrzm-ArGfaa7dNNj2vnvTaJXhxuC-qH58_LS-_zq6uv3y7XFzNDG9YnkmpcdNzSUnXamrkisi600RgYdqGYuhYR6FvV5oxITHtJW4Elz0F3hCKyYpdVB_3vuO0GqAz4HPUTo3RDjpuVdBWnSrebtQ63CrOmGyZKAZvDwYx_JwgZTXYZMA57SFMSRHZiLqt64YV9PU_6E2YYnlwUpTWtBact_wvtdYOlPV9KH3NzlQtOKspFrypCzX_D1VOB4M1wUNvS_6k4M1RwQa0y5sU3LT7s3QKvtuDJoaUIvQPwyBY7fZOXS-X6vt-7wr96nh-D-z9orE_vdPVXg</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Wang, Lun</creator><creator>Yang, Dong</creator><creator>Lv, Jun-Yuan</creator><creator>Yu, Dan</creator><creator>Xin, Shi-Jie</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis</title><author>Wang, Lun ; Yang, Dong ; Lv, Jun-Yuan ; Yu, Dan ; Xin, Shi-Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-88a07f5821d9a2c8b184da1606c9720ed3d2ef9ba336802f807658f2e571201b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biopsy</topic><topic>Cancer surgery</topic><topic>Carbon</topic><topic>Care and treatment</topic><topic>Dissection</topic><topic>Endoscopy</topic><topic>Lymph node excision</topic><topic>Lymphatic system</topic><topic>Meta-analysis</topic><topic>Metastasis</topic><topic>Nanomaterials</topic><topic>Nanoparticles</topic><topic>Nanotubes</topic><topic>Original Research</topic><topic>Parathyroid diseases</topic><topic>Patients</topic><topic>Risk factors</topic><topic>Systematic review</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Lun</creatorcontrib><creatorcontrib>Yang, Dong</creatorcontrib><creatorcontrib>Lv, Jun-Yuan</creatorcontrib><creatorcontrib>Yu, Dan</creatorcontrib><creatorcontrib>Xin, Shi-Jie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>OncoTargets and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Lun</au><au>Yang, Dong</au><au>Lv, Jun-Yuan</au><au>Yu, Dan</au><au>Xin, Shi-Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis</atitle><jtitle>OncoTargets and therapy</jtitle><addtitle>Onco Targets Ther</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>10</volume><spage>1247</spage><epage>1260</epage><pages>1247-1260</pages><issn>1178-6930</issn><eissn>1178-6930</eissn><abstract>To investigate whether carbon nanoparticles (CNs) are helpful in identifying lymph nodes and metastatic lymph nodes and in parathyroid protection during thyroid cancer surgery. English and Chinese literature in PubMed, Cochrane Database of Systematic Reviews, EMBASE, ClinicalTrials.gov, China Biology Medicine Database, China National Knowledge Infrastructure, China Master's and Doctoral Theses Full-Text Database, Wanfang database, and Cqvip database were searched (till March 22, 2016). Randomized controlled trials (RCTs) that compared the use of CNs with a blank control in patients undergoing thyroid cancer surgery were included. Quality assessment and data extraction were performed, and a meta-analysis was conducted using RevMan 5.1 software. The primary outcomes were the number of retrieved central lymph nodes and metastatic lymph nodes, and the rate of accidental parathyroid removal. We obtained 149 relevant studies, and only 47 RCTs with 4,605 patients (CN group: n=2,197; blank control group: n=2,408) met the inclusion criteria. Compared with the control group, the CN group was associated with more retrieved lymph nodes/patient (weighted mean difference [WMD]: 3.39, 95% confidence interval [CI]: 2.73-4.05), more retrieved metastatic lymph nodes (WMD: 0.98, 95% CI: 0.61-1.35), lower rate of accidental parathyroid removal, and lower rates of hypoparathyroidism and hypocalcemia. However, the total metastatic rate of the retrieved lymph nodes did not differ between the groups (odds ratio: 1.13, 95% CI: 0.87-1.47, =0.35). CNs can improve the extent of neck dissection and protect the parathyroid glands during thyroid cancer surgery. And the number of identified metastatic lymph nodes can be simultaneously increased.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>28280359</pmid><doi>10.2147/ott.s131012</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-6930
ispartof OncoTargets and therapy, 2017-01, Vol.10, p.1247-1260
issn 1178-6930
1178-6930
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5338936
source Open Access: PubMed Central; Taylor & Francis Open Access; ProQuest - Publicly Available Content Database
subjects Biopsy
Cancer surgery
Carbon
Care and treatment
Dissection
Endoscopy
Lymph node excision
Lymphatic system
Meta-analysis
Metastasis
Nanomaterials
Nanoparticles
Nanotubes
Original Research
Parathyroid diseases
Patients
Risk factors
Systematic review
Thyroid cancer
title Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A32%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%20carbon%20nanoparticles%20in%20lymph%20node%20dissection%20and%20parathyroid%20protection%20during%20thyroid%20cancer%20surgeries:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=OncoTargets%20and%20therapy&rft.au=Wang,%20Lun&rft.date=2017-01-01&rft.volume=10&rft.spage=1247&rft.epage=1260&rft.pages=1247-1260&rft.issn=1178-6930&rft.eissn=1178-6930&rft_id=info:doi/10.2147/ott.s131012&rft_dat=%3Cgale_pubme%3EA534206574%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c573t-88a07f5821d9a2c8b184da1606c9720ed3d2ef9ba336802f807658f2e571201b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2242465595&rft_id=info:pmid/28280359&rft_galeid=A534206574&rfr_iscdi=true